MICHELLE MESZAR: Open Payments
NPI 1609178623 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 25 payments from 8 companies in 2025. Trend: 2023 $587 · 2024 $962 · 2025 $683
Food & beverage: $583Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $200 |
| Alkermes, Inc. | 5 | $138 |
| Lundbeck LLC | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| ABBVIE INC. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: ARISTADA, ABILIFY ASIMTUFII, UZEDY, COBENFY, VRAYLAR, INVEGA SUSTENNA, FANAPT.
Industry payments across CA — which companies pay providers there.
